Atara Biotherapeutics, Inc.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Jan 17, 2025 S-8
8-K Jan 16, 2025 8-K
8-K Dec 23, 2024 8-K
4 Nov 20, 2024
4 Nov 20, 2024
4 Nov 20, 2024
144 Nov 18, 2024
144 Nov 18, 2024
144 Nov 18, 2024
144 Nov 18, 2024
SC 13G/A Nov 14, 2024
SC 13G/A Nov 14, 2024 SC 13G/A
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
SC 13G/A Nov 12, 2024
SC 13G/A Nov 4, 2024
8-K Oct 15, 2024 8-K
SC 13G/A Sep 13, 2024 SC 13G/A
4 Sep 11, 2024
3 Sep 5, 2024 OWNERSHIP DOCUMENT
SC 13D/A Sep 5, 2024 SC 13D/A
424B5 Sep 4, 2024 424B5
8-K Sep 3, 2024 8-K
4 Aug 20, 2024
4 Aug 20, 2024
← Newer Page 6 of 46 · 1130 filings Older →